Cryptogenic multifocal ulcerating stenosing enteritis and other under-recognised small bowel inflammatory...

Area of Science:

• Gastroenterology
• Genetics
• Pathology

Background:

• Enteropathies are increasingly detected due to advanced diagnostic tools like capsule endoscopy.
• Cryptogenic multifocal ulcerating stenosing enteritis (CNSU), or chronic nonspecific multiple ulcers of the small intestine, is a rare condition of unknown cause.
• Differentiating CNSU from other small bowel inflammatory disorders is crucial for accurate diagnosis and management.

Purpose of the Study:

• To review diagnostic approaches for CNSU.
• To differentiate CNSU from other small bowel inflammatory conditions.
• To highlight recent genetic discoveries in the etiology of CNSU.

Main Methods:

• Review of recent genetic studies on CNSU.
• Analysis of diagnostic criteria for small bowel inflammatory disorders.
• Correlation of genetic findings with clinical presentation.

Main Results:

• SLCO2A1 gene mutations are identified in some CNSU patients, leading to 'chronic enteropathy associated with SLCO2A1'.
• PLA2G4A gene mutations cause cytosolic phospholipase A2α deficiency, resulting in severe ulcerating, stenosing, and fistulating small bowel disease.
• Nonsteroidal anti-inflammatory drug (NSAID) use can mimic CNSU symptoms through prostaglandin inhibition.

Conclusions:

• Prostaglandin-related enteropathy should be considered in patients with atypical small bowel ulceration and stenosis.
• Genetic analysis for SLCO2A1 and PLA2G4A mutations aids in specific diagnosis.
• Thorough patient history, including medication use and urinary metabolite screening, is essential to rule out NSAID-induced enteropathy.